Out of 6,540 patients involved in a study, 7.1% of those with AD had mobility impairment compared to 3.9% of those without AD ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.

Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

But there are multiple forms of eczema, Hu says, and they can start to affect you as a child, as an adult or even ...

HealthDay News — The U.S. Food and Drug Administration has approved Vtama (tapinarof) 1 percent cream for an additional indication — the topical treatment of atopic dermatitis in adult and pediatric ...

Approximately 20-30% of people who seek medical attention for vulvar concerns have vulvar dermatitis. Atopic dermatitis—a type of eczema—is caused by a combination of genetic (inherited ...

However, new epidemiological patterns are slowly emerging, such as atopic dermatitis prevalence increasing in low-income countries and new atopic dermatitis-onset in adults becoming increasingly more ...

Cibniqo and Rinvoq are approved for adults and children 12 years and older. JAK inhibitors interfere with an enzyme that usually promotes inflammation. The drugs work by selectively blocking pathways ...

HAMPTON, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that the Company has initiated a Phase 2 study of barzolvolimab in atopic dermatitis (AD ...